One such candidate might be statin therapy, administration of which has been found to attenuate circulating CRP concentration (Albert et al., 2001) and has also been associated with a reduction in cognitive symptoms among individuals with Alzheimer’s disease (Sparks et al., 2006). The gene discussed is CRP; the disease is Alzheimer disease.